Charter Trust Co. bought a new position in Omega Healthcare Investors Inc (NYSE:OHI) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 6,720 shares of the real estate investment trust’s stock, valued at approximately $220,000.
Several other institutional investors have also bought and sold shares of the business. First Republic Investment Management Inc. lifted its position in shares of Omega Healthcare Investors by 9.8% in the third quarter. First Republic Investment Management Inc. now owns 968,093 shares of the real estate investment trust’s stock valued at $31,725,000 after acquiring an additional 86,508 shares in the last quarter. Renaissance Technologies LLC purchased a new position in shares of Omega Healthcare Investors in the third quarter valued at about $18,889,000. Riverhead Capital Management LLC lifted its position in shares of Omega Healthcare Investors by 39.0% in the third quarter. Riverhead Capital Management LLC now owns 35,965 shares of the real estate investment trust’s stock valued at $1,178,000 after acquiring an additional 10,100 shares in the last quarter. Mutual of America Capital Management LLC lifted its position in shares of Omega Healthcare Investors by 1.0% in the third quarter. Mutual of America Capital Management LLC now owns 172,293 shares of the real estate investment trust’s stock valued at $5,646,000 after acquiring an additional 1,691 shares in the last quarter. Finally, JPMorgan Chase & Co. lifted its position in shares of Omega Healthcare Investors by 24.7% in the third quarter. JPMorgan Chase & Co. now owns 1,132,923 shares of the real estate investment trust’s stock valued at $37,126,000 after acquiring an additional 224,549 shares in the last quarter. 73.42% of the stock is owned by institutional investors and hedge funds.
NYSE:OHI opened at $37.30 on Friday. The company has a current ratio of 4.17, a quick ratio of 4.17 and a debt-to-equity ratio of 1.21. The stock has a market capitalization of $7.59 billion, a P/E ratio of 11.30, a PEG ratio of 7.33 and a beta of 0.17. Omega Healthcare Investors Inc has a 12 month low of $24.90 and a 12 month high of $38.34.
Omega Healthcare Investors (NYSE:OHI) last posted its earnings results on Monday, November 5th. The real estate investment trust reported $0.28 EPS for the quarter, missing analysts’ consensus estimates of $0.74 by ($0.46). The firm had revenue of $192.30 million during the quarter, compared to analysts’ expectations of $194.40 million. Omega Healthcare Investors had a return on equity of 7.32% and a net margin of 31.91%. Omega Healthcare Investors’s quarterly revenue was down .9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.79 earnings per share. On average, equities research analysts anticipate that Omega Healthcare Investors Inc will post 2.97 EPS for the current year.
The company also recently announced a quarterly dividend, which was paid on Thursday, November 15th. Investors of record on Wednesday, October 31st were given a $0.66 dividend. The ex-dividend date of this dividend was Tuesday, October 30th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 7.08%. Omega Healthcare Investors’s dividend payout ratio is currently 80.00%.
Several equities analysts have recently commented on OHI shares. Stifel Nicolaus boosted their price objective on Omega Healthcare Investors to $34.00 in a research report on Sunday, December 2nd. Mitsubishi UFJ Financial Group restated a “neutral” rating on shares of Omega Healthcare Investors in a research report on Tuesday, October 2nd. Bank of America upgraded Omega Healthcare Investors from an “underperform” rating to a “neutral” rating and set a $35.00 price objective on the stock in a research report on Friday, November 16th. TheStreet upgraded Omega Healthcare Investors from a “c” rating to a “b-” rating in a research report on Thursday, November 8th. Finally, MED started coverage on Omega Healthcare Investors in a research report on Tuesday, October 2nd. They issued a “neutral” rating and a $31.00 price objective on the stock. They noted that the move was a valuation call. Seven analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $32.50.
In related news, insider Michael Ritz sold 3,000 shares of the business’s stock in a transaction dated Wednesday, November 28th. The stock was sold at an average price of $37.00, for a total value of $111,000.00. Following the sale, the insider now directly owns 3,076 shares in the company, valued at $113,812. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders sold 11,000 shares of company stock worth $390,500 over the last quarter. 1.65% of the stock is owned by company insiders.
Omega Healthcare Investors Company Profile
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Featured Article: Exchange-Traded Funds (ETFs)
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.